ArticleInflammopharmacology2019

Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3 in the synovial fibroblasts of patients with rheumatoid arthritis.

Yi Sle Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.